fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Protein modifies thyroid hormone levels according to body temperature

Written by | 13 Feb 2014

The thyroid hormone thyroxine, which controls our day-to-day activity and was previously believed to remain at a constant level in the blood, actually fluctuates as a result of… read more.

ASH 2012 Report – Reduced intensity regimen prior to marrow transplant better for older leukaemia patients

Written by | 21 Dec 2012

A new study led by researchers at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC –… read more.

ASH 2012 Report – Novel therapeutic agents provide hope for patients with hard-to-treat blood disorders

Written by | 21 Dec 2012

Encouraging safety and efficacy data on novel and emerging therapies presented at the 54th Annual Meeting of the American Society of Haematology (ASH) signal an important step forward… read more.

ASH 2012 Report – New stem cell research, transplant strategies show promise to improve outcomes, reduce complications

Written by | 21 Dec 2012

Studies of stem cell biology and transplant approaches presented at the 54th Annual Meeting of the American Society of Haematology (ASH) illustrate how the use of advanced modelling… read more.

ASH 2012 Report – New research helps predict susceptibility to Burkitt lymphoma

Written by | 21 Dec 2012

New research, presented at the 54th Annual Meeting of the American Society of Haematology (ASH), has identified important associations between Plasmodium falciparum (Pf) malaria and endemic Burkitt Lymphoma (eBL) that… read more.

ASH 2012 Report – New drug cuts risk of transplant side effect in half

Written by | 21 Dec 2012

by Sung Choi, M.D., University of Michigan Comprehensive Cancer Center (pictured) First study in humans shows promise for preventing graft-versus-host disease following bone marrow transplant.

ASH 2012 Report – Investigational agent targets gene signaling pathways to improve response for patients with CLL

Written by | 21 Dec 2012

The promising investigational targeted therapy ibrutinib and its mechanism of silencing gene communication pathways critical to the development of cancer may be an effective way to combat chronic… read more.

ASH 2012 Report – Experimental graft-vs.-host disease treatment equivalent to standard care in Phase 3 trial

Written by | 21 Dec 2012

An experimental drug combination for preventing graft-versus-host disease (GVHD) was not significantly better than the standard regimen on key endpoints, according to a report of a phase 3… read more.

ASH 2012 Report – Blood levels of immune protein predict risk in Hodgkin disease

Written by | 21 Dec 2012

Blood levels of an immunity-related protein, galectin-1, in patients with newly diagnosed Hodgkin lymphoma reflected the extent of their cancer and correlated with other predictors of outcome,

EAHP 2012 Report – Compassionate use and off-label medicines

Written by | 3 Aug 2012

by Zara Qadir reporting on the presentation by Yechiel Hekster (pictured), Professor of Clinical Pharmacy, and a member of The Netherlands Medicines Evaluation Board.

Report from Cork branch Irish Association for Nurses in Oncology meeting 21st April 2012

Written by | 12 Jun 2012

In order to promote the ongoing education in cancer care which is one of the objectives of the association the Cork branch holds an annual education update. In… read more.

The Mater Institute of Research & Therapy(MIRT) MD-PHD mentorship programme

Written by | 12 Jun 2012

A key goal of MIRT is to train and mentor the clinician scientists of the future. An Interview with Dr. Peter O’Gorman, Consultant Haematologist, at the Mater University… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.